Supplement/Warfarin Interactions Reviewed In AJHP Article
This article was originally published in The Tan Sheet
Executive Summary
Numerous dietary supplements, including coenzyme Q10 and dong quai, may cause adverse events due to possible interactions with the Rx anticoagulant warfarin, an article in the July 1 American Journal of Health-System Pharmacy notes.
You may also be interested in...
St. John's Wort, Rx Drug Use Warning Adopted By CHPA
Consumer Healthcare Products Association member companies soon will be incorporating a prescription drug use warning on their St. John's wort supplements.
Ephedra Alkaloid Content Markedly Different From Label Claims - Study
Controlled, human trials are needed to determine the safety and efficacy of ephedra supplements containing stimulant ingredients, University of Arkansas for Medical Sciences College of Pharmacy researchers say in a study slated to appear in the May 15 issue of the American Journal of Health-System Pharmacy.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC